Markets:

Overview

News

Currencies

International

Treasuries

TrueBlue, Inc. Common Stock (NY:TBI)

10.14 +0.24 (+2.47%)

Streaming Delayed Price Updated: 3:49 PM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TrueBlue, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Looking Into TrueBlue's Return On Capital Employed ↗

October 25, 2022

According to Benzinga Pro data TrueBlue (NYSE:TBI) posted a 13.81% decrease in earnings from Q2. Sales, however, increased by 1.14% over the previous quarter to $575.72 million.

Via Benzinga

TrueBlue Reports Third Quarter 2022 Results

October 24, 2022

From TrueBlue

Via Business Wire

Earnings Scheduled For October 24, 2022 ↗

October 24, 2022

Companies Reporting Before The Bell • Imperial Ptrl (NASDAQ:IMPP) is likely to report earnings for its third quarter.

Via Benzinga

Patrick Beharelle Resigns As TrueBlue CEO Over Conduct Violations ↗

June 15, 2022

Via Benzinga

TrueBlue's Earnings Outlook ↗

October 21, 2022

TrueBlue (NYSE:TBI) is set to give its latest quarterly earnings report on Monday, 2022-10-24. Here's what investors need to know before the announcement. Analysts estimate that TrueBlue will report an...

Via Benzinga

TrueBlue to Announce Third Quarter 2022 Results

October 10, 2022

From TrueBlue

Via Business Wire

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗

July 27, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

12 Industrials Stocks Moving In Tuesday's Intraday Session ↗

July 26, 2022

Via Benzinga

Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session ↗

July 26, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

TrueBlue's Return On Invested Capital Overview ↗

July 26, 2022

According to Benzinga Pro, during Q2, TrueBlue (NYSE:TBI) earned $24.01 million, a 128.28% increase from the preceding quarter. TrueBlue also posted a total of $569.25 million in sales, a 3.22%...

Via Benzinga

TrueBlue Reports Second Quarter 2022 Results

July 25, 2022

From TrueBlue

Via Business Wire

Earnings Scheduled For July 25, 2022 ↗

July 25, 2022

Companies Reporting Before The Bell • Lakeland Financial (NASDAQ:LKFN) is estimated to report quarterly earnings at $0.95 per share on revenue of $59.26 million.

Via Benzinga

Earnings Outlook For TrueBlue ↗

July 22, 2022

TrueBlue (NYSE:TBI) is set to give its latest quarterly earnings report on Monday, 2022-07-25. Here's what investors need to know before the announcement. Analysts estimate that TrueBlue will report an...

Via Benzinga

TrueBlue to Announce Second Quarter 2022 Results

July 11, 2022

From TrueBlue

Via Business Wire

TOP RANKED ROSEN LAW FIRM Encourages TrueBlue, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - TBI

July 03, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

TrueBlue, Inc. (NYSE:TBI) Investor Notice: Investigation over Potential Violations of Securities Laws ↗

June 27, 2022

San Diego, CA -- (SBWIRE) -- 06/27/2022 -- TrueBlue, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

With Unemployment Low, Are Recruiting Tools And Tech Making A Big Difference? ↗

June 27, 2022

A tight labor market makes it challenging for many businesses to hire talented people for open jobs, but using the right recruiting technology might help.

Via Benzinga

TRUEBLUE ALERT: Bragar Eagel & Squire, P.C. is Investigating TrueBlue, Inc. on Behalf of TrueBlue Stockholders and Encourages Investors to Contact the Firm

June 17, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

TRUEBLUE ALERT: Bragar Eagel & Squire, P.C. is Investigating TrueBlue, Inc. on Behalf of TrueBlue Stockholders and Encourages Investors to Contact the Firm

June 16, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in TrueBlue, Inc. with Losses of $100,000 to Contact the Firm

June 16, 2022

From The Schall Law Firm

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in TrueBlue, Inc. with Losses of $100,000 to Contact the Firm

June 15, 2022

From The Schall Law Firm

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages TrueBlue, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – TBI

June 15, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

June 15, 2022

Wednesday's session saw 269 companies set new 52-week lows.

Via Benzinga

Patrick Beharelle Resigns as TrueBlue CEO

June 15, 2022

From TrueBlue, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

May 26, 2022

On Thursday, 94 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022 ↗

May 26, 2022

Upgrades

Via Benzinga

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

April 26, 2022

Gainers Avadel Pharmaceuticals plc. (NASDAQ: AVDL) shares gained 36.3% to $5.74. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday...

Via Benzinga

TrueBlue's Return On Capital Employed Insights ↗

April 26, 2022

According to Benzinga Pro, during Q1, TrueBlue (NYSE:TBI) earned $10.52 million, a 47.95% increase from the preceding quarter. TrueBlue's sales decreased to $551.51 million, a 11.32% change since Q4.

Via Benzinga

TrueBlue Reports First Quarter 2022 Results

April 25, 2022

From TrueBlue

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.